1 report

  • Gastrointestinal Drugs
  • MARKET AND COMPETITIVE ANALYSIS

Over the past 38 years the U.S. Rx-to-OTC market has grown into a $7.8 billion market. This has mainly been due to factors such as patent expirations, increasing competitiveness with the pharmaceutical environment, brand re-invention, consumer demand, and cost containment strategies. The U.S. market for Rx-to-OTC Switches encompasses a wide...

  • Allergy Drug
  • Gastrointestinal Drug
  • OTC
  • United States
  • Procter & Gamble Company